# The-Ozempic-Effect-A-Data-Driven-Analysis-of-Healthcare-s-New-Frontier
A data-driven analysis of GLP-1 agonists (Ozempic, Wegovy, Rybelsus, Trulicity, Mounjaro, Zepbound) exploring their impact on healthcare costs, consumer behavior, and pharma markets using CMS, CDC, FDA, and company financial data.
